FDA cancels pivotal advisory meeting about next season's flu vaccine
FDA cancels meeting to select flu strains for next season's shots
 · 19hWGBH
The FDA has canceled an important upcoming meeting about vaccines
The FDA's Vaccines and Related Biological Products Advisory Committee was scheduled for next month. But the agency notified committee members that the meeting had been canceled.
FDA says Ozempic shortage is over, chilling boom in off-brand versions
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the end to the booming market for cheaper versions made by pharmacies.
FDA and USDA among federal agencies aiming to rehire workers hit by mass firings
Judge blocks Trump administration’s mass firings of federal workers
A federal judge ruled that the terminations at agencies including the Department of Defense were probably illegal.
Judge finds mass firings of federal probationary workers were probably unlawful
Exclusive: FDA staffers told that 'woman,' 'disabled' among banned words; White House says it’s an error
A list with the file name "Prohibited words" has been circulating since at least last week in official work chats, according to two FDA scientists with direct knowledge of the matter.
Abortion pill maker enters legal battle over FDA rules
The country’s only manufacturer of generic abortion medication asked to be a part of the first legal fight over the procedure since President Trump returned to office.  The company, GenBioPro,
Trump Administration Reverses Layoffs At These Federal Agencies—After Cutting Bird Flu, FDA Staff
Some employees at the National Nuclear Security Administration, which oversees the U.S.’ nuclear weapons, were reportedly summoned back to work after being laid off.
Smokescreen: some vape firms pivot after FDA crackdown
Some e-cigarette companies targeted by U.S. authorities have altered their business model or changed their corporate structure, including by transferring operations to offshore firms, according to a U.
Yahoo Finance4d
United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin
The United States FDA Approves the Initiation for Phase II Efficacy Trial in Dermatomyositis (DM) Patients: A Skin & Muscle Disorder CLEVELAND, Feb. 24, 2025 (GLOBE NEWSWIRE) -- NovelMed ...